GlassScriptPhysician profile
Edward St Mary
NPI 1679558720
$787.79
in general payments reported to CMS, 2019-2025
16 companies · $21.49 in 2025
The $21.49 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $118 · 2021: $67.00 · 2022: $57.86 · 2023: $21.19 · 2024: $30.68 · 2025: $21.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $201.51 | 2019-2020 | |
| Amgen INC. | $140.95 | 2019-2020 | |
| Smith+Nephew, INC. | $94.42 | 2020-2023 | Pico, Renasys Go V2 Home |
| Pacira Therapeutics, INC. | $59.52 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $35.53 | 2021 | |
| Ferring Pharmaceuticals INC. | $35.14 | 2019 | |
| Lilly USA, LLC | $32.88 | 2019 | |
| Stryker Corporation | $30.68 | 2024 | |
| Horizon Therapeutics Plc | $27.02 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.21 | 2019 | |
| Endo USA, INC. | $21.49 | 2025 | Xiaflex |
| Reel Surgical, INC. | $19.06 | 2019 | |
| Ucb, INC. | $18.87 | 2019 | |
| Radius Health, INC. | $17.76 | 2019 | |
| Axogen | $16.34 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward St Mary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.